NMPA Approval

Sitagliptin Phosphate and Metformin Hydrochloride Sustained-release Tablets

Approval Number

国药准字H20253646

Company宁波美舒医药科技有限公司

Registration Date

March 18, 2025

Drug Information

Generic Name

西格列汀二甲双胍缓释片

Dosage Form

片剂

Strength

每片含磷酸西格列汀50mg（以C₁₆H₁₅F₆N₅O计）和盐酸二甲双胍500mg

Drug Type

化学药品

Registration Date

March 18, 2025

Company Information

Applicant Company

Company Name宁波美舒医药科技有限公司

Company Address

浙江省宁波高新区扬帆路999弄1号<13-3><14-3>

Manufacturing Company

Company Name宁波美诺华天康药业有限公司

Company Address

浙江省宁波市北仑区大榭街道滨海西路85号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

西格列汀二甲双胍缓释片 - NMPA 批准文号 | MedPath